These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37103226)

  • 1. Vasari Scoring System in Discerning between Different Degrees of Glioma and IDH Status Prediction: A Possible Machine Learning Application?
    Gemini L; Tortora M; Giordano P; Prudente ME; Villa A; Vargas O; Giugliano MF; Somma F; Marchello G; Chiaramonte C; Gaetano M; Frio F; Di Giorgio E; D'Avino A; Tortora F; D'Agostino V; Negro A
    J Imaging; 2023 Mar; 9(4):. PubMed ID: 37103226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond invasive biopsies: using VASARI MRI features to predict grade and molecular parameters in gliomas.
    Setyawan NH; Choridah L; Nugroho HA; Malueka RG; Dwianingsih EK
    Cancer Imaging; 2024 Jan; 24(1):3. PubMed ID: 38167551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinically Available and Reproducible Prediction Models for IDH and CDKN2A/B Gene Status in Adult-type Diffuse Gliomas.
    Zhu M; Han F; Gao J; Yang J; Yin L; Du Z; Zhang J
    Acad Radiol; 2024 Jun; ():. PubMed ID: 38944632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Role of the Apparent Diffusion Coefficient and MRI Morphologic Features on IDH Status in Patients With Diffuse Glioma: A Retrospective Cross-Sectional Study.
    Zhang J; Peng H; Wang YL; Xiao HF; Cui YY; Bian XB; Zhang DK; Ma L
    Front Oncol; 2021; 11():640738. PubMed ID: 34055608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative and Quantitative MRI Analysis in IDH1 Genotype Prediction of Lower-Grade Gliomas: A Machine Learning Approach.
    Cao M; Suo S; Zhang X; Wang X; Xu J; Yang W; Zhou Y
    Biomed Res Int; 2021; 2021():1235314. PubMed ID: 33553421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI Features May Predict Molecular Features of Glioblastoma in
    Park CJ; Han K; Kim H; Ahn SS; Choi D; Park YW; Chang JH; Kim SH; Cha S; Lee SK
    AJNR Am J Neuroradiol; 2021 Mar; 42(3):448-456. PubMed ID: 33509914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten Years of VASARI Glioma Features: Systematic Review and Meta-Analysis of Their Impact and Performance.
    Azizova A; Prysiazhniuk Y; Wamelink IJHG; Petr J; Barkhof F; Keil VC
    AJNR Am J Neuroradiol; 2024 Jun; ():. PubMed ID: 38937115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.
    Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS
    Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy and potential covariates for machine learning to identify IDH mutations in glioma patients: evidence from a meta-analysis.
    Zhao J; Huang Y; Song Y; Xie D; Hu M; Qiu H; Chu J
    Eur Radiol; 2020 Aug; 30(8):4664-4674. PubMed ID: 32193643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. World Health Organization Grade II/III Glioma Molecular Status: Prediction by MRI Morphologic Features and Apparent Diffusion Coefficient.
    Maynard J; Okuchi S; Wastling S; Busaidi AA; Almossawi O; Mbatha W; Brandner S; Jaunmuktane Z; Koc AM; Mancini L; Jäger R; Thust S
    Radiology; 2020 Jul; 296(1):111-121. PubMed ID: 32315266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p/19q status in diffuse low- and high-grade gliomas.
    Zhou H; Chang K; Bai HX; Xiao B; Su C; Bi WL; Zhang PJ; Senders JT; Vallières M; Kavouridis VK; Boaro A; Arnaout O; Yang L; Huang RY
    J Neurooncol; 2019 Apr; 142(2):299-307. PubMed ID: 30661193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric Magnetic Resonance Imaging Correlates of Isocitrate Dehydrogenase Mutation in WHO high-Grade Astrocytomas.
    Sahu A; Patnam NG; Goda JS; Epari S; Sahay A; Mathew R; Choudhari AK; Desai SM; Dasgupta A; Chatterjee A; Pratishad P; Shetty P; Moiyadi AA; Gupta T
    J Pers Med; 2022 Dec; 13(1):. PubMed ID: 36675733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of gliomas grading and IDH status decoding A comparison between 3D amide proton transfer APT and four diffusion-weighted MRI models.
    Guo H; Liu J; Hu J; Zhang H; Zhao W; Gao M; Zhang Y; Yang G; Cui Y
    J Magn Reson Imaging; 2022 Dec; 56(6):1834-1844. PubMed ID: 35488516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Ki-67 expression levels in IDH-wildtype glioblastoma using logistic regression modelling of VASARI features.
    Bai L; Jiang J; Zhou J
    Neurosurg Rev; 2023 Dec; 47(1):20. PubMed ID: 38135816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine learning: a useful radiological adjunct in determination of a newly diagnosed glioma's grade and IDH status.
    De Looze C; Beausang A; Cryan J; Loftus T; Buckley PG; Farrell M; Looby S; Reilly R; Brett F; Kearney H
    J Neurooncol; 2018 Sep; 139(2):491-499. PubMed ID: 29770897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination of radiomics features and VASARI standard to predict glioma grade.
    You W; Mao Y; Jiao X; Wang D; Liu J; Lei P; Liao W
    Front Oncol; 2023; 13():1083216. PubMed ID: 37035137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of
    Park YW; Han K; Ahn SS; Bae S; Choi YS; Chang JH; Kim SH; Kang SG; Lee SK
    AJNR Am J Neuroradiol; 2018 Jan; 39(1):37-42. PubMed ID: 29122763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET.
    Tatekawa H; Hagiwara A; Uetani H; Bahri S; Raymond C; Lai A; Cloughesy TF; Nghiemphu PL; Liau LM; Pope WB; Salamon N; Ellingson BM
    Cancer Imaging; 2021 Mar; 21(1):27. PubMed ID: 33691798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivariable non-invasive association of isocitrate dehydrogenase mutational status in World Health Organization grade II and III gliomas with advanced magnetic resonance imaging T2 mapping techniques.
    Kern M; Auer TA; Fehrenbach U; Tanyildizi Y; Picht T; Misch M; Wiener E
    Neuroradiol J; 2020 Apr; 33(2):160-168. PubMed ID: 31957551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiomics and Qualitative Features From Multiparametric MRI Predict Molecular Subtypes in Patients With Lower-Grade Glioma.
    Sun C; Fan L; Wang W; Wang W; Liu L; Duan W; Pei D; Zhan Y; Zhao H; Sun T; Liu Z; Hong X; Wang X; Guo Y; Li W; Cheng J; Li Z; Liu X; Zhang Z; Yan J
    Front Oncol; 2021; 11():756828. PubMed ID: 35127472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.